Outside-In Perspective for Rare Disease Asset Launch

A Fortune 200 pharmaceutical company needed to develop a resource plan for the launch of a rare disease product with an upcoming phase III readout. To align stakeholders, the VP, Commercial for Rare Disease also needed help creating an executive-level presentation and storyboarding launch activities.

BTG delivered a former McKinsey engagement manager with a PhD, significant commercial and R&D industry experience, and experience leading product launch and GTM initiatives in the US and Europe. The consultant crafted a resource plan for launching the product across four countries, complete with franchise vision, positioning, and an overall narrative.